Home » Glaxo to Pay $250 Million to Settle Avandia Death Lawsuits
Glaxo to Pay $250 Million to Settle Avandia Death Lawsuits
GlaxoSmithKline Plc agreed to pay more than $250 million to resolve about 5,500 claims related to its Avandia diabetes drug and avoid the first trial over claims it kills users, two people familiar with the accords said.
Forex News Paper
Forex News Paper
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May